715 related articles for article (PubMed ID: 11090131)
1. Role of LXRs in control of lipogenesis.
Schultz JR; Tu H; Luk A; Repa JJ; Medina JC; Li L; Schwendner S; Wang S; Thoolen M; Mangelsdorf DJ; Lustig KD; Shan B
Genes Dev; 2000 Nov; 14(22):2831-8. PubMed ID: 11090131
[TBL] [Abstract][Full Text] [Related]
2. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR.
Cha JY; Repa JJ
J Biol Chem; 2007 Jan; 282(1):743-51. PubMed ID: 17107947
[TBL] [Abstract][Full Text] [Related]
3. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors.
Joseph SB; Laffitte BA; Patel PH; Watson MA; Matsukuma KE; Walczak R; Collins JL; Osborne TF; Tontonoz P
J Biol Chem; 2002 Mar; 277(13):11019-25. PubMed ID: 11790787
[TBL] [Abstract][Full Text] [Related]
4. The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression.
Pawar A; Botolin D; Mangelsdorf DJ; Jump DB
J Biol Chem; 2003 Oct; 278(42):40736-43. PubMed ID: 12917410
[TBL] [Abstract][Full Text] [Related]
5. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta.
Repa JJ; Liang G; Ou J; Bashmakov Y; Lobaccaro JM; Shimomura I; Shan B; Brown MS; Goldstein JL; Mangelsdorf DJ
Genes Dev; 2000 Nov; 14(22):2819-30. PubMed ID: 11090130
[TBL] [Abstract][Full Text] [Related]
6. Coadministration of a liver X receptor agonist and a peroxisome proliferator activator receptor-alpha agonist in Mice: effects of nuclear receptor interplay on high-density lipoprotein and triglyceride metabolism in vivo.
Beyer TP; Schmidt RJ; Foxworthy P; Zhang Y; Dai J; Bensch WR; Kauffman RF; Gao H; Ryan TP; Jiang XC; Karathanasis SK; Eacho PI; Cao G
J Pharmacol Exp Ther; 2004 Jun; 309(3):861-8. PubMed ID: 14960661
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles.
Grefhorst A; Elzinga BM; Voshol PJ; Plösch T; Kok T; Bloks VW; van der Sluijs FH; Havekes LM; Romijn JA; Verkade HJ; Kuipers F
J Biol Chem; 2002 Sep; 277(37):34182-90. PubMed ID: 12097330
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of sterol regulatory element-binding protein 1c transcriptional activity by insulin and liver X receptor during liver development.
Bobard A; Hainault I; Ferré P; Foufelle F; Bossard P
J Biol Chem; 2005 Jan; 280(1):199-206. PubMed ID: 15509573
[TBL] [Abstract][Full Text] [Related]
9. Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression.
Seo JB; Moon HM; Kim WS; Lee YS; Jeong HW; Yoo EJ; Ham J; Kang H; Park MG; Steffensen KR; Stulnig TM; Gustafsson JA; Park SD; Kim JB
Mol Cell Biol; 2004 Apr; 24(8):3430-44. PubMed ID: 15060163
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor.
Inaba T; Matsuda M; Shimamura M; Takei N; Terasaka N; Ando Y; Yasumo H; Koishi R; Makishima M; Shimomura I
J Biol Chem; 2003 Jun; 278(24):21344-51. PubMed ID: 12672813
[TBL] [Abstract][Full Text] [Related]
11. Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalpha.
Lehrke M; Lebherz C; Millington SC; Guan HP; Millar J; Rader DJ; Wilson JM; Lazar MA
Cell Metab; 2005 May; 1(5):297-308. PubMed ID: 16054077
[TBL] [Abstract][Full Text] [Related]
12. Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.
Green CD; Jump DB; Olson LK
Endocrinology; 2009 Jun; 150(6):2637-45. PubMed ID: 19228891
[TBL] [Abstract][Full Text] [Related]
13. Keratinocyte growth factor and the transcription factors C/EBP alpha, C/EBP delta, and SREBP-1c regulate fatty acid synthesis in alveolar type II cells.
Mason RJ; Pan T; Edeen KE; Nielsen LD; Zhang F; Longphre M; Eckart MR; Neben S
J Clin Invest; 2003 Jul; 112(2):244-55. PubMed ID: 12865412
[TBL] [Abstract][Full Text] [Related]
14. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation.
Chu K; Miyazaki M; Man WC; Ntambi JM
Mol Cell Biol; 2006 Sep; 26(18):6786-98. PubMed ID: 16943421
[TBL] [Abstract][Full Text] [Related]
15. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
16. A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα.
Ducheix S; Podechard N; Lasserre F; Polizzi A; Pommier A; Murzilli S; Di Lisio C; D'Amore S; Bertrand-Michel J; Montagner A; Pineau T; Loiseau N; Lobaccaro JM; Martin PG; Guillou H
Biochimie; 2013 Mar; 95(3):556-67. PubMed ID: 23063693
[TBL] [Abstract][Full Text] [Related]
17. The role of LXR alpha in goose primary hepatocyte lipogenesis.
Han C; Wang J; Li L; Wang L; Zhang Z
Mol Cell Biochem; 2009 Feb; 322(1-2):37-42. PubMed ID: 18975056
[TBL] [Abstract][Full Text] [Related]
18. Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor.
Quinet EM; Savio DA; Halpern AR; Chen L; Miller CP; Nambi P
J Lipid Res; 2004 Oct; 45(10):1929-42. PubMed ID: 15292374
[TBL] [Abstract][Full Text] [Related]
19. LXR-SREBP-1c-phospholipid transfer protein axis controls very low density lipoprotein (VLDL) particle size.
Okazaki H; Goldstein JL; Brown MS; Liang G
J Biol Chem; 2010 Feb; 285(9):6801-10. PubMed ID: 20037162
[TBL] [Abstract][Full Text] [Related]
20. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice.
Peng D; Hiipakka RA; Dai Q; Guo J; Reardon CA; Getz GS; Liao S
J Pharmacol Exp Ther; 2008 Nov; 327(2):332-42. PubMed ID: 18723776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
